Traduction de «re-assuring data about » (Néerlandais → Français) :

The Superior Health Council takes due note of the fact that the European Authorities have made available re-assuring data about the innocuousness of two of the main ingredients of energy drinks, namely taurine and D-glucuronolactone.
Le Conseil Supérieur de la Santé prend acte de la mise à disposition par les autorités européennes de données rassurantes sur l’innocuité de deux principaux composants des boissons énergisantes, à savoir la taurine et la D-glucuronolactone.

" Compliance with this standard (= GCP) provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible.‰
ÿ Compliance with this standard (= GCP) provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with the princinciples that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible. Ÿ

They should also settle on the agreements that can be made in that region about the providing care to and referring of patients as well as the handling of recurrences. In order to achieve this aim, the authorities may consider providing support to local programmes, following-up on regional data and co-ordinating local health professionals.
Pour y parvenir, les autorités peuvent envisager le soutien de programmes locaux, le suivi des données régionales et la coordination des professionnels de la santé locaux.

By contrast, collecting data about attempted suicides is a much more delicate matter, as not all attempted suicides are taken to the hospitals’ emergency services, or even to a doctor.
Par contre, le recueil de données sur les tentatives de suicide est beaucoup plus délicat, dans la mesure où elles ne sont pas toutes orientées vers les services d’urgence des hôpitaux, ni même vers un médecin.

Additional data about MRSA colonised or infected patients (numerator):
Les données supplémentaires au sujet de patients colonisés ou infectés par MRSA (numérateur)

In a report of 15 January 2009, the European Food Safety Authority (EFSA) gives its opinion about the innocuousness of taurine and D-glucuronolactone as individual ingredients of energy drinks. This is based on new data from the literature and recent studies by the same applicant (EFSA, 2009).
Enfin, dans un rapport du 15 janvier 2009, l’European Food Safety Authority (EFSA) se prononce sur l’innocuité de la taurine et de la D-glucuronolactone en tant qu’ingrédients individuels de boissons énergisantes en se fondant sur les données récentes de la littérature et de nouvelles études fournies par le même pétitionnaire mais ne procède pas à une évaluation de l’innocuité de ces boissons en tant que telles (EFSA, 2009).

Data input happens manually. Information about the bookings, such as the reconciliation of fees and the corresponding service applications, is mainly obtained from the MeSeA system, more specifically through verification of the “public inbox payment tracking”.
Data input happens manually. Information about the bookings, such as the reconciliation of fees and the corresponding service applications, is mainly obtained from the MeSeA system, more specifically through verification of the “public inbox payment tracking”.

In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.
In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.